A virocidal arnphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro

被引:122
作者
Cheng, Guofeng [1 ]
Montero, Ana [2 ]
Gastaminza, Pablo [1 ]
Whitten-Bauer, Christina [1 ]
Wieland, Stefan F. [1 ]
Isogawa, Masanori [1 ]
Fredericksen, Brenda [4 ]
Selvarajah, Suganya [3 ]
Gallay, Philippe A. [3 ]
Ghadiri, M. Reza [2 ]
Chisari, Francis V. [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[4] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA
关键词
HCV; amphipathic peptide; antiviral peptide; NS5A; HIV;
D O I
10.1073/pnas.0712380105
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
An amphipathic a-helical peptide (C5A) derived from the membrane anchor domain of the hepatitis C virus (HCV) NS5A protein is virocidal for HCV at submicromolar concentrations in vitro. C5A prevents de novo HCV infection and suppresses ongoing infection by inactivating both extra- and intracellular infectious particles, and it is nontoxic in vitro and in vivo at doses at least 100-fold higher than required for antiviral activity. Mutational analysis indicates that C5A's amphipathic a-helical structure is necessary but not sufficient for its virocidal activity, which depends on its amino acid composition but not its primary sequence or chirality. In addition to HCV, C5A inhibits infection by selected flaviviruses, paramyxoviruses, and HIV. These results suggest a model in which C5A destabilizes viral membranes based on their lipid composition, offering a unique therapeutic approach to HCV and other viral infections.
引用
收藏
页码:3088 / 3093
页数:6
相关论文
共 37 条
  • [1] Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome
    Alter, HJ
    Seeff, LB
    [J]. SEMINARS IN LIVER DISEASE, 2000, 20 (01) : 17 - 35
  • [2] STRUCTURE AND ORIENTATION OF THE ANTIBIOTIC PEPTIDE MAGAININ IN MEMBRANES BY SOLID-STATE NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY
    BECHINGER, B
    ZASLOFF, M
    OPELLA, SJ
    [J]. PROTEIN SCIENCE, 1993, 2 (12) : 2077 - 2084
  • [3] Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane
    Booth, AM
    Fang, Y
    Fallon, JK
    Yang, JM
    Hildreth, JEK
    Gould, SJ
    [J]. JOURNAL OF CELL BIOLOGY, 2006, 172 (06) : 923 - 935
  • [4] An amino-terminal amphipathic α-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A
    Brass, V
    Bieck, E
    Montserret, R
    Wölk, B
    Hellings, JA
    Blum, HE
    Penin, F
    Moradpour, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) : 8130 - 8139
  • [5] Human α-defensins block papillomavirus infection
    Buck, CB
    Day, PM
    Thompson, CD
    Lubkowski, J
    Lu, WY
    Lowy, DR
    Schiller, JT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1516 - 1521
  • [6] HIV entry and its inhibition
    Chan, DC
    Kim, PS
    [J]. CELL, 1998, 93 (05) : 681 - 684
  • [7] Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides
    Chinchar, VG
    Bryan, L
    Silphadaung, U
    Noga, E
    Wade, D
    Rollins-Smith, L
    [J]. VIROLOGY, 2004, 323 (02) : 268 - 275
  • [8] CHUNG BH, 1985, J BIOL CHEM, V260, P256
  • [9] New therapeutic strategies for hepatitis C
    Di Bisceglie, AM
    McHutchinson, J
    Rice, CM
    [J]. HEPATOLOGY, 2002, 35 (01) : 224 - 231
  • [10] Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication
    Elazar, M
    Cheong, KH
    Liu, P
    Greenberg, HB
    Rice, CM
    Glenn, JS
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (10) : 6055 - 6061